Skip to content
healthcare.dev

PREVDUO

NDC 42023-269, neostigmine methylsulfate and glycopyrrolate, injection, from Endo USA.

Product NDC
42023-269
Status
Listed
Labeler
Endo USA
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216903
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42023-269 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL
  • GLYCOPYRROLATE.2 mg/mL

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
42023-269-05420230269055 SYRINGE, PLASTIC in 1 CARTON (42023-269-05) / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd8ad38f-247b-4948-a13c-8f3a4921b4f1

Use it

Look up 42023-269 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42023-269 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42023-269. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.